Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.

Gómez CE, Nájera JL, Perdiguero B, García-Arriaza J, Sorzano CO, Jiménez V, González-Sanz R, Jiménez JL, Muñoz-Fernández MA, López Bernaldo de Quirós JC, Guardo AC, García F, Gatell JM, Plana M, Esteban M.

J Virol. 2011 Nov;85(21):11468-78. doi: 10.1128/JVI.05165-11. Epub 2011 Aug 24.

PMID:
21865377
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Poxvirus vectors as HIV/AIDS vaccines in humans.

Gómez CE, Perdiguero B, Garcia-Arriaza J, Esteban M.

Hum Vaccin Immunother. 2012 Sep;8(9):1192-207. doi: 10.4161/hv.20778. Epub 2012 Aug 21. Review.

PMID:
22906946
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Development of a DNA-MVA/HIVA vaccine for Kenya.

Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV.

Vaccine. 2002 May 6;20(15):1995-8. Review.

PMID:
11983261
[PubMed - indexed for MEDLINE]
4.

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.

Hanke T, Goonetilleke N, McMichael AJ, Dorrell L.

J Gen Virol. 2007 Jan;88(Pt 1):1-12. Review. Erratum in: J Gen Virol. 2008 Feb;89(Pt 2):609. Goonetilleke, Nilu [added].

PMID:
17170430
[PubMed - indexed for MEDLINE]
Free Article
5.

Induction of immunity to human immunodeficiency virus type-1 by vaccination.

McElrath MJ, Haynes BF.

Immunity. 2010 Oct 29;33(4):542-54. doi: 10.1016/j.immuni.2010.09.011. Review.

PMID:
21029964
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

STEP trial and HIV-1 vaccines inducing T-cell responses.

Hanke T.

Expert Rev Vaccines. 2008 Apr;7(3):303-9. doi: 10.1586/14760584.7.3.303. Review.

PMID:
18393600
[PubMed - indexed for MEDLINE]
7.

Clinical applications of attenuated MVA poxvirus strain.

Gómez CE, Perdiguero B, García-Arriaza J, Esteban M.

Expert Rev Vaccines. 2013 Dec;12(12):1395-416. doi: 10.1586/14760584.2013.845531. Epub 2013 Oct 30. Review.

PMID:
24168097
[PubMed - indexed for MEDLINE]
8.

Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.

Boukhebza H, Bellon N, Limacher JM, Inchauspé G.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1746-57. doi: 10.4161/hv.21689. Epub 2012 Aug 16. Review.

PMID:
22894957
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Vaccine applications of flow cytometry.

De Rosa SC.

Methods. 2012 Jul;57(3):383-91. doi: 10.1016/j.ymeth.2012.01.001. Epub 2012 Jan 10. Review.

PMID:
22251671
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.

Cruz LJ, Rueda F, Tacken P, Albericio F, Torensma R, Figdor CG.

Nanomedicine (Lond). 2012 Oct;7(10):1591-610. doi: 10.2217/nnm.12.131. Review.

PMID:
23148541
[PubMed - indexed for MEDLINE]
11.

Strategies for the achievement of prophylactic vaccination against HIV.

Hilleman MR.

Antibiot Chemother (1971). 1996;48:161-72. Review. No abstract available.

PMID:
8726521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk